- Developing Antiretroviral Drugs for Treatment Guidance for Industry🔍
- A Timeline of HIV and AIDS🔍
- CMS Statement on FDA Accelerated Approval of Lecanemab🔍
- ViiV Healthcare announces US FDA approval of Triumeq PD ...🔍
- U.S. Food and Drug Administration 🔍
- FDA Approves Merck's WINREVAIR™ 🔍
- FTC Issues Policy Statement on Brand Pharmaceutical ...🔍
- FDA approves pretomanid for highly drug|resistant forms of TB🔍
Statement from Treatment Action Group on U.S. FDA Approval of ...
Developing Antiretroviral Drugs for Treatment Guidance for Industry
response in other patient groups, the FDA may conclude the benefits of these combinations ... For initial approvals (Groups 1 to 3), depending on the ...
1987 · April 29: FDA approves a new, more specific test for HIV antibodies: the Western blot blood test kit. · May 15: The U.S. Public Health Service adds HIV as ...
CMS Statement on FDA Accelerated Approval of Lecanemab
“At CMS, we will continue to expeditiously review the data on these products as they become available and are committed to timely access to ...
Developing paediatric formulations of anti-retroviral treatments is a priority for ViiV Healthcare because we want to ensure that no one living ...
U.S. Food and Drug Administration (FDA) Accepts Supplemental ...
U.S. FDA has assigned a target action date of June 21, 2024 ... FDA-approved test, who have received at least one prior systemic therapy.
HIV News, Press Release and Statements | ViiV Healthcare US
... treatment for children living with HIV. 30 Mar 2022. ViiV Healthcare announces US FDA approval of Cabenuva (cabotegravir, rilpivirine) for virologically ...
FDA Approves Merck's WINREVAIR™ (sotatercept-csrk), a First-in ...
In the WINREVAIR treatment group, the placebo-adjusted median ... Forward-Looking Statement of Merck & Co., Inc., Rahway, N.J., USA.
FTC Issues Policy Statement on Brand Pharmaceutical ...
The policy statement emphasizes that “[p]atents improperly listed in the Orange Book can significantly undermine competition and harm the ...
FDA approves pretomanid for highly drug-resistant forms of TB
Read the full statement from Treatment Action Group (TAG) on FDA approval of pretomanid here. ... approved in United States. Science Speaks ...
How ACT UP Changed America | The New Yorker
The defiant group of AIDS activists was itself riven by discord. Michael Specter on Sarah Schulman's “Let the Record Show,” and what we can ...
FDA APPROVALS, LICENSURES & CLEARANCES FOR BARDA ...
BARDA supports a diverse portfolio of medical countermeasures and these products have received a total of 95 FDA approvals, licensures, or clearances.
Today, the U.S. Food and Drug Administration approved and granted emergency use authorization ... Today, the U.S. Food and Drug Administration took action on ...
Veopoz™ (pozelimab-bbfg) Receives FDA Approval as the First ...
(NASDAQ: REGN) today announced the U.S. Food and Drug Administration (FDA) has approved Veopoz™ (pozelimab-bbfg) for the treatment of adult and ...
Applied Therapeutics Provides FDA Update on PDUFA Target ...
In February 2024, the Company announced that the FDA accepted and granted Priority Review to the NDA. Govorestat was previously granted ...
ANKTIVA FDA Approval: First-in-Class IL-15 Agonist for NMIBC
CULVER CITY, Calif., April 22, 2024 — ImmunityBio, Inc. (NASDAQ: IBRX), an immunotherapy company, today announced that the U.S. Food and Drug ...
FDA Advisory Committee recommends accelerated approval of ...
... United States Food and Drug Administration (FDA). The committee ... AIDS activist organisation Treatment Action Group (TAG), along with ...
FDA Approves Lilly's Zepbound™ (tirzepatide) for Chronic Weight ...
INDIANAPOLIS , Nov. 8, 2023 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) approved Eli Lilly and Company's (NYSE: LLY) Zepbound™ (tirzepatide) ...
New TB drug approval a milestone, all agree -- with caveats, some add
8/15/2019 Facebook Twitter LinkedIn Email The announcement Wednesday of U.S. ... FDA to encourage development of drugs to treat ... statement from the Treatment ...
Statement from the Pancreatic Cancer Action Network on U.S. FDA ...
“We are pleased that the FDA has approved the NALIRIFOX regimen. For a tough disease with few treatment options, this is significant news for ...
Incyte and Syndax Announce U.S. FDA Approval of Niktimvo ...
Incyte and Syndax Announce U.S. FDA Approval of Niktimvo™ (axatilimab-csfr) for the Treatment of Chronic Graft-Versus-Host Disease (GVHD).